What is the registration number for NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION?

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION is registered under USPTO registration number 7401968.

NCO

USPTO Trademark Record

REGISTERED

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION

Q: Who owns the NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark?

The NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark is owned by National Community Oncology Dispensing Association, Inc..

Q: What class is the NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark registered in?

The NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION?

The USPTO serial number for NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION is 98149193.

SN 98149193·Reg 7401968·Filed Aug 24, 2023

Owner National Community Oncology Dispensing Association, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION (Serial No. 98149193), Registration No. 7401968, is a registered US trademark filed on Aug 24, 2023 by National Community Oncology Dispensing Association, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: May 28, 2030

Mark Intelligence

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION (Reg. #7401968) is a registered US trademark that has been protecting its owner, National Community Oncology Dispensing Association, Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 24, 2023

SERIAL

98149193

REG#

7401968

REGISTERED

May 28, 2024

Owner

Applicant

National Community Oncology Dispensing Association, Inc.

Entity

Corporation

State

Address

5345 Indian Lookout Road, 5345 Indian Lookout Road, Cazenovia, NY, 13035

Country

Attorney

NameJeffrey Mustari, Esq.

Law firm

Jeffrey Mustari, Esq. SOUTHERN HEALTH LAWYERS, LLC (A SANDERS & MUSTARI

Address

3 ALLIANCE CENTER, 3550 LENOX RD., NE, SUITE 2100, ATLANTA, GA 30326, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 24, 2023

Serial Number98149193

Registration No.7401968

Registration DateMay 28, 2024

Status DateMay 28, 2024

Published for OppositionMar 12, 2024

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 19, 2021

First use in commerce: Oct 19, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

May 28, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 28, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Mar 12, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 12, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 21, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 21, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 05, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 02, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 01, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 01, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 03, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 03, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 03, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 30, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 28, 2023

NEW APPLICATION ENTERED

NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by National Community Oncology Dispensing Association, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jeffrey Mustari, Esq.

Resources

Company